Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Alaunos Therapeutics (TCRT) Debt Ratio (2016 - 2023)

Alaunos Therapeutics (TCRT) has disclosed Debt Ratio for 4 consecutive years, with 0.23 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Debt Ratio fell 21.04% year-over-year to 0.23, compared with a TTM value of 0.23 through Mar 2023, down 21.04%, and an annual FY2022 reading of 0.26, up 1.55% over the prior year.
  • Debt Ratio was 0.23 for Q1 2023 at Alaunos Therapeutics, down from 0.26 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.34 in Q3 2022 and bottomed at 0.21 in Q3 2021.
  • Average Debt Ratio over 3 years is 0.27, with a median of 0.26 recorded in 2022.
  • The sharpest move saw Debt Ratio surged 58.16% in 2022, then fell 21.04% in 2023.
  • Year by year, Debt Ratio stood at 0.25 in 2021, then rose by 1.55% to 0.26 in 2022, then decreased by 12.5% to 0.23 in 2023.
  • Business Quant data shows Debt Ratio for TCRT at 0.23 in Q1 2023, 0.26 in Q4 2022, and 0.34 in Q3 2022.